Agency Information Collection Activities; Proposed eCollection, eComments Requested; Extension Without Change of a Previously Approved Collection; Collection of Laboratory Analysis Data on Drug Samples Tested by Non-Federal (State and Local Government) Crime Laboratories, 4930 [2016-01677]
[Federal Register Volume 81, Number 18 (Thursday, January 28, 2016)]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-01677]
DEPARTMENT OF JUSTICE
[OMB Number 1117-0034]
Agency Information Collection Activities; Proposed eCollection,
eComments Requested; Extension Without Change of a Previously Approved
Collection; Collection of Laboratory Analysis Data on Drug Samples
Tested by Non-Federal (State and Local Government) Crime Laboratories
AGENCY: Drug Enforcement Administration, Department of Justice.
ACTION: 30-Day notice.
SUMMARY: The Department of Justice (DOJ), Drug Enforcement
Administration (DEA), will be submitting the following information
collection request to the Office of Management and Budget (OMB) for
review and approval in accordance with the Paperwork Reduction Act of
1995. This proposed information collection was previously published in
the Federal Register at 80 FR 73834, November 25, 2015, allowing for a
60-day comment period.
DATES: Comments are encouraged and will be accepted for an additional
30 days until February 29, 2016.
FOR FURTHER INFORMATION CONTACT: If you have comments on the estimated
public burden or associated response time, suggestions, or need a copy
of the proposed information collection instrument with instructions or
additional information, please contact Barbara J. Boockholdt, Office of
Diversion Control, Drug Enforcement Administration; Mailing Address:
8701 Morrissette Drive, Springfield, Virginia 22152; Telephone: (202)
Written comments and/or suggestions can also be directed to the
Office of Management and Budget, Office of Information and Regulatory
Affairs, Attention Department of Justice Desk Officer, Washington, DC
20530 or sent to OIRA_submissions@omb.eop.gov.
SUPPLEMENTARY INFORMATION: Written comments and suggestions from the
public and affected agencies concerning the proposed collection of
information are encouraged. Your comments should address one or more of
the following four points:
--Evaluate whether the proposed collection of information is necessary
for the proper performance of the functions of the agency, including
whether the information will have practical utility;
--Evaluate the accuracy of the agency's estimate of the burden of the
proposed collection of information, including the validity of the
methodology and assumptions used;
--Evaluate whether and if so how the quality, utility, and clarity of
the information proposed to be collected can be enhanced; and
--Minimize the burden of the collection of information on those who are
to respond, including through the use of appropriate automated,
electronic, mechanical, or other forms of information technology, e.g.,
permitting electronic submission of responses.
Overview of this information collection:
1. Type of Information Collection: Extension of a currently
2. Title of the Form/Collection: Collection of Laboratory Analysis
Data on Drug Samples Tested by Non-Federal (State and Local Government)
3. The agency form number, if any, and the applicable component of
the Department sponsoring the collection: There are no applicable forms
associated with this collection. The applicable component within the
Department of Justice is the Drug Enforcement Administration, Office of
4. Affected public who will be asked or required to respond, as
well as a brief abstract:
Affected public (Primary): Business or other for-profit.
Affected public (Other): Not-for-profit institutions; Federal,
State, local, and tribal governments.
Abstract: This collection provides the Drug Enforcement
Administration (DEA) with a national database on analyzed drug evidence
from non-federal laboratories. Information from this database is
combined with the other existing databases to develop more accurate,
up-to-date information on abused drugs. This database represents a
voluntary, cooperative effort on the part of participating laboratories
to provide a centralized source of analyzed drug data.
5. An estimate of the total number of respondents and the amount of
time estimated for an average respondent to respond: The DEA estimates
that 140 persons respond annually for this collection at 1.6 hours per
respondent, for an annual burden of 218 hours.
6. An estimate of the total public burden (in hours) associated
with the proposed collection: The DEA estimates that this collection
takes 218 annual burden hours.
If additional information is required please contact: Jerri Murray,
Department Clearance Officer, United States Department of Justice,
Justice Management Division, Policy and Planning Staff, Two
Constitution Square, 145 N Street NE., Suite 3E.405B, Washington, DC
Dated: January 25, 2016.
Department Clearance Officer for PRA, U.S. Department of Justice.
[FR Doc. 2016-01677 Filed 1-27-16; 8:45 am]
BILLING CODE 4410-09-P